MYD88 and ovarian carcinoma: The novel analysis of miR-21 and miR-146a expression in this study, based on the categorization of EOC into MyD88 positive and MyD88 negative, demonstrates that expression of both MyD88 and these microRNAs are linked to ovarian cancer.